- Home
- SIGA vs PSBD Comparison
SIGA vs PSBD Comparison
Compare SIGA & PSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGA
- PSBD
- Stock Information
- Founded
- SIGA 1995
- PSBD 2009
- Country
- SIGA United States
- PSBD United States
- Employees
- SIGA N/A
- PSBD N/A
- Industry
- SIGA Biotechnology: Pharmaceutical Preparations
- PSBD
- Sector
- SIGA Health Care
- PSBD
- Exchange
- SIGA Nasdaq
- PSBD Nasdaq
- Market Cap
- SIGA 422.9M
- PSBD 462.9M
- IPO Year
- SIGA 1997
- PSBD 2024
- Fundamental
- Price
- SIGA $6.52
- PSBD $13.86
- Analyst Decision
- SIGA
- PSBD Buy
- Analyst Count
- SIGA 0
- PSBD 4
- Target Price
- SIGA N/A
- PSBD $14.13
- AVG Volume (30 Days)
- SIGA 418.3K
- PSBD 43.5K
- Earning Date
- SIGA 07-31-2025
- PSBD 08-07-2025
- Dividend Yield
- SIGA 9.02%
- PSBD 12.43%
- EPS Growth
- SIGA N/A
- PSBD N/A
- EPS
- SIGA 0.67
- PSBD N/A
- Revenue
- SIGA $120,330,310.00
- PSBD N/A
- Revenue This Year
- SIGA N/A
- PSBD N/A
- Revenue Next Year
- SIGA $95.31
- PSBD N/A
- P/E Ratio
- SIGA $9.91
- PSBD N/A
- Revenue Growth
- SIGA N/A
- PSBD N/A
- 52 Week Low
- SIGA $4.95
- PSBD $11.51
- 52 Week High
- SIGA $12.83
- PSBD $16.85
- Technical
- Relative Strength Index (RSI)
- SIGA 57.63
- PSBD 63.29
- Support Level
- SIGA $6.01
- PSBD $14.48
- Resistance Level
- SIGA $6.49
- PSBD $14.98
- Average True Range (ATR)
- SIGA 0.25
- PSBD 0.31
- MACD
- SIGA 0.00
- PSBD 0.02
- Stochastic Oscillator
- SIGA 75.32
- PSBD 68.57
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About PSBD Palmer Square Capital BDC Inc.
Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.